KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $209.2 million.

  • Adaptive Biotechnologies' Non-Current Assets fell 1638.38% to $209.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $953.9 million, marking a year-over-year decrease of 272.99%. This contributed to the annual value of $255.6 million for FY2024, which is 186.41% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Non-Current Assets stood at $209.2 million for Q3 2025, which was down 1638.38% from $234.8 million recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Non-Current Assets peaked at $525.6 million during Q3 2021, and registered a low of $209.2 million during Q3 2025.
  • Its 5-year average for Non-Current Assets is $313.6 million, with a median of $287.7 million in 2023.
  • Per our database at Business Quant, Adaptive Biotechnologies' Non-Current Assets skyrocketed by 14096.46% in 2021 and then tumbled by 4343.58% in 2022.
  • Over the past 5 years, Adaptive Biotechnologies' Non-Current Assets (Quarter) stood at $520.6 million in 2021, then plummeted by 43.44% to $294.5 million in 2022, then decreased by 14.78% to $250.9 million in 2023, then grew by 1.86% to $255.6 million in 2024, then fell by 18.17% to $209.2 million in 2025.
  • Its Non-Current Assets was $209.2 million in Q3 2025, compared to $234.8 million in Q2 2025 and $254.4 million in Q1 2025.